Galactokinase promiscuity: a question of flexibility?

Area of Science:

• Biochemistry
• Enzyme kinetics
• Metabolic pathways

Background:

• Galactokinase (GALK) catalyzes the initial step in the Leloir pathway, phosphorylating galactose.
• Deficient GALK activity leads to type II galactosaemia.
• Inhibiting GALK is a therapeutic strategy for severe galactosaemia types I and III.

Purpose of the Study:

• To investigate the catalytic mechanism of galactokinase.
• To explore galactokinase as a biocatalyst for sugar 1-phosphate production.
• To engineer galactokinase variants with altered substrate specificity.

Main Methods:

• Structural analysis of galactokinase from various species.
• Experimental and theoretical studies on the catalytic mechanism.
• Enzyme engineering approaches to modify substrate specificity.

Main Results:

• Galactokinase structure is known, but its catalytic mechanism remains debated, with evidence supporting both active site base and alternative mechanisms.
• Engineered galactokinase variants exhibit broader specificity for various D- and L-sugars.
• Increased active site flexibility is observed in engineered variants.

Conclusions:

• Modulating protein flexibility is critical for successful enzyme engineering, alongside structural modifications.
• Understanding galactokinase's mechanism and engineering its properties can advance therapeutic and biocatalytic applications.